domingo, 2 de febrero de 2014

Today’s articles on Investing Ideas

Top Ideas

Galena Biopharma: Numerous Red Flags Suggest A Significant Overvaluation
by Matt Gravitt

Editor's notes: Amid being poised to fail their next pivotal trial and an exuberant rise in shares, a short opportunity presents itself in GALE.

Momenta: Impending Approval Provides Price Support With Excellent Upside Potential
by Buddy Lyons, CFA

Editor's notes: Momenta's M356 approval is almost a certainty, although the recent run-up in shares doesn't yet fully account for this. BioPharma Fund Manager Buddy Lyons sees 50% remaining upside.

Regis: A Turnaround Play With Asymmetric Upside Of 50+%
by Alpha Gen Capital

Editor's notes: Despite getting clipped after recent earnings, RGS's optimization strategy should aid a turnaround. As a leading player in a market less sensitive to the economy, the downside risks seem limited.

Long Ideas

PPL Corporation: Stock With Growth Opportunities by Blackstone Equity Research

Verizon: An Undervalued Stock by Blackstone Equity Research

Acquisitions At Ari Network Services Have Driven Up Revenues by The Marketer

Yum Has Learned To Make Returns Scrumptious by Alpha Strategist

Dow Chemical Set For Big Profits In 2014 by Alpha 7 Trading

Spectrum Pharmaceuticals: Could This Year Mark The Return Of Gains? by Ang Nguyen

Aqua America: A Rare Investment Opportunity by Alpha Source

Coke Vs. Pepsi: Where The Real Difference Lies by Chuck Walston

Inovio Neglected The Sign: Don't Feed The Bears! by Biotech Research Group

Trade WPCS International For News Driven Swings But Invest For Bitcoin Revenue by Christopher F. Davis

Kingold Jewelry, A Stock To Watch In The Year Of The Horse by Dutch Trader

Refreshing The Valuation After A Record Quarter At Silicom by Ken Nagy

Whiting Petroleum Has Everything A Value Investor Is Looking For by John Mylant

Potash Corp: Top Contrarian Value With At Least 20% Upside Potential by Achilles Research

Microsoft: Price Momentum Will Persist by Stock Gamer

An Aging Population Should Help Brookdale Senior Living In The Long Run by Ashleigh Rogers

Bullish Outlook For VSE Corp Still Intact Despite Recent Challenges by John Leonard

McEwen Mining And Marlin Gold: Speculative Plays On Gold-Rich Mexico by Derrick Lilly

Will Joy Global Bring Joy To Its Shareholders? by Netwall

SNC-Lavalin: Crisis = Opportunity by Brian Langis

Genesee & Wyoming: Benefiting From Regulation, Acquisitions, And Oil By Rail by ValueArtifex

Short Ideas

The Caterpillar Way - Unjustified Optimism by Yaniv Uliel

New Models From Honda And Audi Will Consign Tesla And Its Superchargers To A Smaller Niche by Logical Thought

Atlantic Power: Is Another Dividend Cut In The Cards? by Albert Alfonso

Navigating Navigant Consulting by Mike Arnold

McEwen Mining May Be Due For A Correction by Itinerant

Quick Picks & Lists

China Biotech In Review: Mindray Acquires Control Of U.S.-China IVD Company by ChinaBio Today

3 Stocks To Own During A Market Meltdown by Eric Parnell

Why Google Is The Top Tech Play Of Our Generation by Markos Kaminis

2 Energy Plays Bucking The Trend by Bret Jensen

Cramer's Picks

Cramer's Mad Money - 11 Earnings To Watch In The Week Ahead (1/31/14) by SA Editor Miriam Metzinger

Cramer's Lightning Round - Groupon Has Depth (1/31/14) by SA Editor Miriam Metzinger

Insider Ownership

Discover Financial: 6 Different Insiders Have Sold Shares This Year by Markus Aarnio

Juniper Networks: 3 Different Insiders Have Sold Shares This Year by Markus Aarnio

AMN Healthcare: 3 Different Insiders Have Sold Shares Last Month by Markus Aarnio

IPO Analysis

Lloyds: Announced IPO Can Be A Resounding Success by Antonio Carradinha

Biotech Boomlet Set To Smash IPO Record For Two-Week Period by Renaissance Capital IPO Research


Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001

No hay comentarios:

Publicar un comentario